Drugs Made In America Acquisition Corp. (DMAA) stock
Close on Nov 13, 2026Market cap $264.62MP/E –Yield –
Drugs Made In America Acquisition statistics
46 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (QoQ)
- 0.00%
- 0.00%
- Float
- 20M
- 24M
- Shares Held by Insiders
- 18.9%
- 18.2%
- Shares Held by Institutions
- 57.5%
- 69.2%
Short sellingIndustry
- Short Interest
- 85,523
- –
- Short Interest Change
- -4.00%
- 0.52%
- Days to Cover
- 4.95
- 1.00
Stock price statisticsIndustry
- 52-Week High
- $10.91
- –
- 52-Week Low
- $10.31
- –
- 20-Day Moving Average
- $10.88
- –
- 50-Day Moving Average
- $10.86
- –
- 200-Day Moving Average
- $10.66
- –
- Average True Range (14)
- $0.01
- –
- Price Change (1 Week)
- 0.09%
- 0.10%
- Price Change (1 Month)
- 0.28%
- 0.38%
- Price Change (3 Months)
- 1.68%
- 0.40%
- Price Change (6 Months)
- 2.98%
- 1.35%
- Price Change (YTD)
- 5.07%
- 2.76%
- Price Change (1 Year)
- 5.62%
- 1.94%
- Average Volume (10 Days)
- 9,394
- –
- Average Volume (20 Days)
- 14,577
- –
- Average Volume (90 Days)
- 20,377
- –
- Relative Strength Index (14)
- 68.3
- 56.1
- Volatility (1 Year)
- 1.85%
- 17.8%
Returns on capitalIndustry
- Return on Assets (ROA)
- 3.19%
- 1.56%
- Return on Capital Employed (ROCE)
- -1.83%
- -0.86%
Financial positionIndustry
- Current Ratio
- 0.02
- 2.24
- Quick Ratio
- 0.01
- 1.56
EfficiencyIndustry
- Profits Per Employee
- $609.49K
- $81.67K
- Employee Count
- 10
- 67
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $20.28K
- $866.50K
- Net Cash Per Share
- $0.00
- $0.04
- Equity (Book Value)
- -$7.41M
- -$170.61K
- Book Value Per Share
- -$0.31
- -$0.01
- Tangible Book Value
- -$7.41M
- -$412.80K
- Working Capital
- -$2.88M
- $357.41K
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- 2.30%
- 2.16%
Scores and fair valueIndustry
- Altman Z-Score
- 17.22
- 10.24
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | DMAA | S&P 500 | Difference | DMAA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +0.4% | -3.0% | +3.4 pts | ||
| 3 months | +1.8% | -2.8% | +4.6 pts | ||
| Year to date | +5.1% | +11.5% | −6.4 pts | ||
| 1 year | +5.6% | +13.5% | −7.8 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M DMAA shares were sold short on Oct 30, 2026, down 4.0% from the previous report. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 16.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 85,523 | -4.0% | 17,289 | 5.0 |
| Oct 15, 2026 | 89,088 | -0.8% | 10,699 | 8.3 |
| Sep 30, 2026 | 89,787 | -3.0% | 889 | 101.0 |
| Sep 15, 2026 | 92,523 | +16.5% | 70,510 | 1.3 |
| Aug 31, 2026 | 79,392 | -1.5% | 15,749 | 5.0 |
| Aug 14, 2026 | 80,595 | -9.1% | 517 | 155.9 |
| Jul 31, 2026 | 88,655 | -5.6% | 17,395 | 5.1 |
| Jul 15, 2026 | 93,894 | +13.1% | 60,138 | 1.6 |
| Jun 30, 2026 | 82,989 | +8.4% | 35,869 | 2.3 |
| Jun 15, 2026 | 76,532 | -12.0% | 36,048 | 2.1 |
| May 29, 2026 | 86,950 | -9.9% | 58,516 | 1.5 |
| May 15, 2026 | 96,507 | -7.0% | 7,384 | 13.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?